Patent intelligence · US
US 8703727
Nanotechnology formulation of poorly soluble compounds
Nanotechnology formulation of poorly soluble compounds
Patent details — US 8703727
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 22, 2014
- Expiration
- Apr 17, 2034
- Applicant
- Aphios Corporation
- Claims
- 10
- CPC classes
- A61K, A61K31/133, A61K31/167, A61K31/352
Quick answer
US 8703727 (Nanotechnology formulation of poorly soluble compounds) is held by Aphios Corporation. Status: granted. Granted Apr 22, 2014. Expires Apr 17, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aphios Corporation
- Grant date
- Expiration
- Claims
- 10
- CPC classes
- A61K, A61K31/133, A61K31/167, A61K31/352, A61K31/395, A61K31/404
More from Aphios Corporation
Related pharmaceutical patents in our USPTO index.
-
US 11926828
Methods for treating aging and skin disorders using nucleic acids targeting TYR or MMP1
granted -
US 11639359
Bryoid compositions, methods of making and use thereof
granted -
US 11584933
RNA interference in ocular indications
granted -
US 11396654
Neutral nanotransporters
granted -
US 11279934
Methods for treating cancer using nucleic acids targeting MDM2 or MYCN
granted -
US 11254940
Inhibition of MAP4K4 through RNAi
granted -
US 11234932
Combination HIV therapeutic
granted -
US 11118178
Reduced size self-delivering RNAI compounds
granted
Frequently asked questions
What is US patent 8703727?
US 8703727 (Nanotechnology formulation of poorly soluble compounds) is held by Aphios Corporation. Status: granted. Granted Apr 22, 2014. Expires Apr 17, 2034 (8 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 8703727?
Aphios Corporation is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 39 pharmaceutical patents for this assignee.
When does US 8703727 expire?
Our index shows an expiration date of Apr 17, 2034 (8 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.